Chronic Pain Syndrome Clinical Trial
Official title:
A Mobile Intervention on Values in Chronic Pain Patients.
NCT number | NCT05205889 |
Other study ID # | SCA0222 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | February 15, 2022 |
Est. completion date | May 31, 2022 |
Verified date | October 2022 |
Source | Philipps University Marburg Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study aims to test a mobile intervention on values and goals in chronic pain patients. The cognitive behavioral intervention is a 10-day course in which participants complete a brief intervention each day (about 10-20 minutes a day). The content of the intervention includes the definition of values; development of individualized values and personal value-oriented goals; and implementation of personal goals in every day life. To assess the effectiveness of the intervention, we use a multiple baseline single case design. Baseline measurements will be assessed daily between 10 and 17 days (the exact number will be randomized). Daily measurements will continue during the intervention. After the intervention, another post measurement will be collected.
Status | Completed |
Enrollment | 30 |
Est. completion date | May 31, 2022 |
Est. primary completion date | April 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Chronic, non-tumor related back pain (pain for at least 6 months) - Ownership of a smartphone - Numeric Rating Scale for pain result of = 4 Exclusion Criteria: - High cognitive impairment (e.g., intellectual disability) - Currently in psychotherapeutic treatment - Initiation of pain-focused treatment during the study |
Country | Name | City | State |
---|---|---|---|
Germany | University of Marburg | Marburg | Hessen |
Lead Sponsor | Collaborator |
---|---|
Philipps University Marburg Medical Center |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Pain intensity | Numerical Pain Rating Scale (NPRS) Minimum value: 0; Maximum value: 10 (higher scores indicate higher pain intensity) | Pain intensity is assessed daily from baseline to the end of treatment (resulting in 20-27 measuring time points) | |
Secondary | Change in psychological well-being | The five-item WHO Well-Being Index (WHO-5) Minimum value: 0; Maximum value 10 (range is adapted for the study; higher scores indicate higher psychological well-being) | Psychological well-being is assessed daily from baseline to the end of treatment (resulting in 20-27 measuring time points) | |
Secondary | Change in chronic pain acceptance | Chronic Pain Acceptance Questionnaire (CPAQ) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher pain acceptance) | Chronic Pain Acceptance is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points) | |
Secondary | Change in engaged living | Engaged Living Scale (ELS) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher engaged living) | Engaged Living is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points) | |
Secondary | Change in pain catastrophizing | Pain Catastrophizing Scale (PCS) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher catastrophizing) | Pain Catastrophizing is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points) | |
Secondary | Change in psychological flexibility | Acceptance and Action Questionnaire 2 (AAQ-2) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate lower psychological flexibility) | Psychological Flexibility is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points) | |
Secondary | Change in self-efficacy | Pain Self-efficacy Questionnaire (PSEQ) Minimum value: 0; Maximum value: 10 (range is adapted for the study; higher scores indicate higher self-efficacy) | Self-efficacy is assessed daily from baseline to the end of the study (resulting in 20-27 measuring time points) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01417923 -
The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain
|
Phase 4 | |
Completed |
NCT03472521 -
Prevention of Persistent Opioid Use in Mothers
|
Phase 4 | |
Not yet recruiting |
NCT03249025 -
Lidocaine-Ketamine for Management of Chronic Pain
|
N/A | |
Enrolling by invitation |
NCT06359561 -
Assessment of Effectiveness and Stimulation Coverage of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Patients With Cervical Lead Placement
|
||
Recruiting |
NCT05877274 -
Sodium Channel Mutations in Patient With the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)
|
||
Completed |
NCT03317782 -
NoL Index Variations Before and After a Stellate Ganglion Block
|
||
Completed |
NCT04199858 -
Electrophysiological Correlates of Nocebo Effects on Pain
|
N/A | |
Recruiting |
NCT05491499 -
Assessing the Impact of Exercise Based Intensive Interdisciplinary Pain Treatment (IIPT) on Endogenous Pain Modulation in Youth With Chronic Pain Syndromes
|
||
Active, not recruiting |
NCT05090683 -
Evaluation of a Mind-body Based Application for the Treatment of Chronic/Persistent Pain.
|
N/A | |
Completed |
NCT04197154 -
Pain-related Fear as a Facilitator of Nocebo Hyperalgesia
|
N/A | |
Completed |
NCT04209764 -
Prevalence of Pain in the Departments of Surgery and Oncoematology of a Children's Hospital
|
||
Recruiting |
NCT06072560 -
Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
|
Phase 3 | |
Recruiting |
NCT06071949 -
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
|
Phase 3 | |
Recruiting |
NCT06071962 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain
|
Phase 3 | |
Recruiting |
NCT06072001 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
|
Phase 3 | |
Recruiting |
NCT06071936 -
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
|
Phase 3 | |
Recruiting |
NCT06071988 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy
|
Phase 3 | |
Recruiting |
NCT06072573 -
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
|
Phase 3 | |
Recruiting |
NCT06071975 -
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
|
Phase 3 | |
Completed |
NCT03460717 -
Thermal Micro-cautery for Painful Knee Osteoarthritis
|
N/A |